美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=NIRAVAM
符合检索条件的记录共4
1 页 当前第 1 页  返回检索页
1药品名称NIRAVAM
申请号021726产品号001
活性成分ALPRAZOLAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/01/19申请机构UCB INC
2药品名称NIRAVAM
申请号021726产品号002
活性成分ALPRAZOLAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/01/19申请机构UCB INC
3药品名称NIRAVAM
申请号021726产品号003
活性成分ALPRAZOLAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/01/19申请机构UCB INC
4药品名称NIRAVAM
申请号021726产品号004
活性成分ALPRAZOLAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2005/01/19申请机构UCB INC